SavedAdd your journal

Journals / Clinical and Experimental Health Sciences / 2020 / Cilt: 10 - Sayı: 2

In-vitro anticandidial efficacy of tick egg wax from Hyalomma marginatum, Rhipicephalus bursa and Dermacentor marginatus

Berna Erdal
Çağla Bozkurt Güzel
Nazlı Bilgin
Mayram Hacıoğlu
Sırrı Kar
Pages
108–112
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: In the previous studies, the antibacterial, antifungal, and antiviral efficacy of the tick egg wax-coating of certain tick species were

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In the previous studies, the antibacterial, antifungal, and antiviral efficacy of the tick egg wax-coating of certain tick species were
📊
Key Findings & Data:Objective: In the previous studies, the antibacterial, antifungal, and antiviral efficacy of the tick egg wax-coating of certain tick species were
💡
Conclusion & Impact:Objective: In the previous studies, the antibacterial, antifungal, and antiviral efficacy of the tick egg wax-coating of certain tick species were
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antifungals · tick egg wax · Rhipicephalus bursa

Abstract

Objective: In the previous studies, the antibacterial, antifungal, and antiviral efficacy of the tick egg wax-coating of certain tick species were

🔖

Cite This Article

Erdal, B., Güzel, Ç. B., Bilgin, N., Hacıoğlu, M., Kar, S. (2022). In-vitro anticandidial efficacy of tick egg wax from Hyalomma marginatum, Rhipicephalus bursa and Dermacentor marginatus. Clinical and Experimental Health Sciences, Cilt: 10 - Sayı: 2, 108–112. https://ajindex.com/articles/474312

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. da Silva Dantas A, Lee KK, Raziunaite I, Schaefer K, Wagener J, Yadav B, Gow NAR. Cell biology of Candida albicans–host interactions. Curr Opin Microbiol 2016; 34: 111-118
  2. Vengurlekar S, Sharma R, Trivedi P. Efficacy of some natural compounds as antifungal agents. Pharmacogn Rev 2012; 6: 91-99
  3. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11: 142-151
  4. Papon N, Courdavault V, Clastre M, Bennett RJ. Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLoS Pathog 2013; 9: e1003550
  5. Jahagirdar VL, Davane MS, Aradhye SC, Nagoba BS. Candida species as potential nosocomial pathogens - A review. Electron J Gen Med 2018; 15: em05
  6. Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS and Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol 2017; 7: 2173
  7. Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist 2017; 10: 249-259
  8. Jensen RH, Astvad KMT, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations. J Antimicrob Chemother 2015; 70: 2551-2555
  9. Wang H, Xu YC, Hsueh PR. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future Microbiol 2016; 11:11
  10. Sarma S, Upadhyay S. Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect Drug Resist 2017; 10: 155-165
  11. Shen B. A new golden age of natural products drug discovery. Cell 2015; 163: 1297-1300
  12. Abad MJ, Ansuategui M, Bermejo P. Active antifungal substances from natural sources. Arkivoc 2007; 7: 116-145
  13. Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013; 62: 10-24
  14. Wang S, Wang Q, Yang E, Yan L, Li T, Zhuang H. Antimicrobial compounds produced by vaginal Lactobacillus crispatus are able to strongly inhibit Candida albicans growth, hyphal formation and regulate virulence-related gene expressions. Front Microbiol 2017; 8: 564
  15. Wright AE, Bothelo JC, Guzman E, Harmody D, Linley P, McCarthy PJ, Pitts